SL
NKTR icon

Signition LP’s Nektar Therapeutics NKTR Stock Holding History

Signition LP’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,896
Closed -$1.01M – 141
2019
Q2 		$1.01M Buy
1,896
+355
+23% +$178K 0.67% 61
2019
Q1 		$776K Sell
1,541
-240
-13% -$142K 0.53% 66
2018
Q4 		$878K Sell
1,781
-39
-2% -$23.5K 0.56% 64
2018
Q3 		$1.66M Buy
+1,820
New +$1.55M 0.84% 36

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Signition LP's NKTR Position: Q3 2019 in Review

Signition LP sold out of Nektar Therapeutics (NKTR) in Q3 2019, closing a stake of 1,896 shares — an estimated $1.01M sold.

Signition LP first reported a position in NKTR in Q3 2018 and held it in 4 quarters. The position peaked at $1.66M in Q3 2018. 287 funds tracked by Wall St. Rank hold NKTR as of Q3 2019.

  • Signition LP reported no remaining Nektar Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Signition LP sold 1,896 Nektar Therapeutics shares in Q3 2019, an estimated $1.01M.
  • Signition LP first reported a position in Nektar Therapeutics in Q3 2018 and held it in 4 quarters.
  • Signition LP's Nektar Therapeutics position peaked at $1.66M in Q3 2018.
  • 287 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2019.

Based on Signition LP's 13F filing for Q3 2019, filed 5 Nov 2019.